Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Torque Teno Virus quantification for monitoring of immunomodulation with biologic compounds in the treatment of rheumatoid arthritis.
Studenic P, Bond G, Kerschbaumer A, Bécède M, Pavelka K, Karateev D, Stieger J, Puchner R, Mueller RB, Puchhammer-Stöckl E, Durechova M, Loiskandl M, Perkmann T, Olejarova M, Luchikhina E, Steiner CW, Bonelli M, Smolen JS, Aletaha D. Studenic P, et al. Among authors: becede m. Rheumatology (Oxford). 2022 Jul 6;61(7):2815-2825. doi: 10.1093/rheumatology/keab839. Rheumatology (Oxford). 2022. PMID: 34792562 Clinical Trial.
Information technology concerning SDAI and CDAI.
Aletaha D, Bécède M, Smolen JS. Aletaha D, et al. Among authors: becede m. Clin Exp Rheumatol. 2016 Sep-Oct;34(5 Suppl 101):S45-S48. Epub 2016 Oct 18. Clin Exp Rheumatol. 2016. PMID: 27762194 Free article. Review.
Risk profiling for a refractory course of rheumatoid arthritis.
Bécède M, Alasti F, Gessl I, Haupt L, Kerschbaumer A, Landesmann U, Loiskandl M, Supp GM, Smolen JS, Aletaha D. Bécède M, et al. Semin Arthritis Rheum. 2019 Oct;49(2):211-217. doi: 10.1016/j.semarthrit.2019.02.004. Epub 2019 Feb 8. Semin Arthritis Rheum. 2019. PMID: 30799033 Free article.
Characteristics and outcome of critically ill patients with systemic rheumatic diseases referred to the intensive care unit.
Schneeweiss-Gleixner M, Hillebrand C, Jaksits S, Fries J, Zauner M, Heinz G, Sengölge G, Staudinger T, Zauner C, Aletaha D, Machold KP, Schellongowski P, Bécède M. Schneeweiss-Gleixner M, et al. Among authors: becede m. RMD Open. 2023 Nov 29;9(4):e003287. doi: 10.1136/rmdopen-2023-003287. RMD Open. 2023. PMID: 38030230 Free PMC article.
Elimination of Doripenem during Dialysis and Pharmacokinetic Evaluation of Posthemodialysis Dosing for Patients Undergoing Intermittent Renal Replacement Therapy.
Vossen MG, Ehmann L, Pferschy S, Maier-Salamon A, Haidinger M, Weiser C, Wenisch JM, Saria K, Kajahn C, Jilch S, Lemmerer R, Bécède M, Zeitlinger M, Kloft C, Jäger W, Thalhammer F. Vossen MG, et al. Among authors: becede m. Antimicrob Agents Chemother. 2018 Apr 26;62(5):e02430-17. doi: 10.1128/AAC.02430-17. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29530855 Free PMC article. Clinical Trial.